CTOs on the Move

Avation Medical

www.avation.com

 
Avation Medical is an innovative advanced neuromodulation and digital health company pioneering closed-loop, patient-friendly, wearable neuromodulation therapies that deliver personalized therapy based on the patient`s own physiologic response. The Company`s intelligent wearable therapies objectively confirm activation of the target nerve and make neuromodulation technology accessible to millions of patients across a variety of clinical application by eliminating need for surgery, needles and permanent implants and shifting therapy into the home environment.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.avation.com
  • 1375 Perry Street
    Columbus, OH USA 43201
  • Phone: 614.591.4201

Executives

Name Title Contact Details

Similar Companies

HealthCare Plus

HealthCare Plus is a Polson, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Apherma Corp

Apherma Corp is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oasis Medical

Oasis Medical, Inc. is a Glendora, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smith and Nephew

Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange   We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.   We have almost 11,000 employees and a presence in more than 90 countries.   Annual sales in 2013 were more than $4.3 billion.   We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)

Nextremity Solutions

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the musculoskeletal space, offering innovative solutions and Revenue Ready® products for various musculoskeletal applications and for the benefit of our industry partners. The Companys procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.